ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ROIV Roivant Sciences Ltd

10.9868
0.2668 (2.49%)
Jun 18 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Roivant Sciences Ltd ROIV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.2668 2.49% 10.9868 19:00:00
Open Price Low Price High Price Close Price Previous Close
10.74 10.68 10.865 10.84 10.72
more quote information »

Recent News

Date Time Source Heading
5/30/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/30/202415:46EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
5/30/202406:45EDGAR2Form 8-K - Current report
5/30/202406:15EDGAR2Form 8-K - Current report
5/30/202406:00GLOBERoivant Reports Financial Results for the Fourth Quarter and..
5/22/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/22/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/22/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/16/202415:05GLOBERoivant to Report Financial Results for the Fourth Quarter..
4/02/202406:00GLOBERoivant Announces Positive NEPTUNE Study Results for..
3/26/202417:22PRNUSRoivant Sciences Set to Join S&P MidCap 400; Sunrun to Join..
2/13/202406:00GLOBERoivant Reports Financial Results for the Third Quarter..
1/30/202415:05GLOBERoivant to Report Financial Results for the Third Quarter..
12/20/202315:30GLOBERoivant Reports Positive Initial Phase 2 Results for..
12/14/202308:00GLOBERoche Completes Acquisition of Telavant from Roivant,..
11/28/202306:00GLOBERoivant Announces Positive IMVT-1402 Initial 600 mg MAD..
11/27/202307:00GLOBERoivant and Priovant Announce Results from Phase 2 Study of..
11/13/202306:00GLOBERoivant Reports Financial Results for the Second Quarter..
11/10/202307:00GLOBERoivant Announces Appointment of Mayukh Sukhatme to Its..
10/30/202316:30GLOBERoivant to Report Financial Results for the Second Quarter..
10/23/202314:41DJNTrending: Roche to Buy Telavant From Roivant and Pfizer
10/23/202306:18IHMARKETNEWSMonday’s Wall Street Highlights: Philips, Chevron,..
10/23/202303:16DJNRoche to Buy Telavant From Roivant, Pfizer in Deal Worth Up..
10/23/202300:50DJNRoche to Buy Telavant From Roivant Sciences and Pfizer in..
10/23/202300:00GLOBERoche Enters Into a Definitive Agreement to Acquire Telavant..
10/13/202307:00GLOBECovant Therapeutics Appoints Vincent Hennemand as Chief..
9/26/202305:00GLOBERoivant Announces Positive Initial IMVT-1402 Phase 1 SAD and..
9/11/202307:00GLOBERoivant Announces Completion of Redemption of its..
8/17/202315:05GLOBERoivant Announces Redemption Fair Market Value in Connection..
8/14/202306:00GLOBERoivant Reports Financial Results for the First Quarter..
8/03/202315:05GLOBERoivant to Report Financial Results for the Quarter Ended..
8/02/202315:05GLOBERoivant Announces Redemption of Outstanding Warrants
7/27/202307:00GLOBETelavant, a Roivant Company, Advances Inflammatory Bowel..
7/14/202306:51IHMARKETNEWSFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase,..
7/11/202307:00GLOBERoivant Ranks No. 25 on Fast Company’s Fifth Annual List of..
6/28/202307:57GLOBEUPDATE -- Roivant Reports Financial Results for the Fourth..
6/28/202306:00GLOBERoivant Reports Financial Results for the Fourth Quarter and..
6/26/202315:05GLOBERoivant to Report Financial Results for the Fourth Quarter..
6/22/202306:30GLOBERoivant Reports Chronic Period Data for RVT-3101 from the..
6/21/202316:00GLOBERoivant to Host Investor Call at 8:00 AM ET on Thursday,..